APA (7th ed.) Citation

LT, P., J, C., GK, B., TH, H., H, M., JH, C., . . . AA, C. (2026). Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 15(2), 100299. https://doi.org/10.1016/j.apjo.2026.100299

Chicago Style (17th ed.) Citation

LT, Phan, et al. "Faricimab for Previously-treated Eyes with Neovascular Age-related Macular Degeneration with Inadequate Response - 6-month Interim Analysis of the FURGGHORN Study." Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.) 15, no. 2 (2026): 100299. https://doi.org/10.1016/j.apjo.2026.100299.

MLA (9th ed.) Citation

LT, Phan, et al. "Faricimab for Previously-treated Eyes with Neovascular Age-related Macular Degeneration with Inadequate Response - 6-month Interim Analysis of the FURGGHORN Study." Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.), vol. 15, no. 2, 2026, p. 100299, https://doi.org/10.1016/j.apjo.2026.100299.